| ¿µ¹® | manic depressive illness(MDI) | ÇÑ±Û | Á¶¿ïº´ |
|---|---|---|---|
| ¼³¸í | Á¶º´°ú ¿ì¿ïº´ÀÌ ¹ø°¥¾Æ °¡¸ç ³ªÅ¸³ª´Â Á¤½Åº´. Á¶º´Àº 3°¡ÁöÀÇ Å« Ư¡À» °¡Áö°í Àִµ¥ ±×°ÍÀº Áö³ªÄ£ Àڽۨ, Áö³ªÄ£ °ú´ÙȰµ¿, ³Ê¹«³ª °í¾çµÈ ±âºÐÀÌ ±×°ÍÀÌ´Ù. µû¶ó¼ ±×µéÀº ¾ð¶æ º¸±â¿£ Àڽۨ¿¡ Â÷¼ ¼¼»óÀ» »ì¾Æ°¡´Â °Íó·³ º¸À̳ª, ½ÇÁ¦ÀûÀ¸·Î´Â ±× ÀÏÀ» ¹úÀ̱⸸ ÇÒ »Ó, ±× ÀÏÀ» °¨´çÇÒ ´É·ÂÀº ¾ø¾î ´ë°³ »ç¾÷À» Çϸé, ÆÄ»êÇϰųª, ³²ÀÇ Àç»êÀ» ÅÁÁøÇϱ⵵ ÇÏ¸é¼ ÀÚ½ÅÀº ¿©ÀüÈ÷ Àڽۨ¼Ó¿¡¼ »ì¾Æ ´Ù¸¥ °¡Á·µé¿¡ ÀÇÇØ¼ ²ø·Á º´¿ø¿¡ ¿À°Ô µÇ´Â °æ¿ì°¡ ¸¹´Ù. ÇÑÆí ¿ïº´Àº Áö³ªÄ¡°Ô ¿ì¿ïÇÑ ±âºÐ, ÀÚ»ìÀÇ¿å, ¶§¿¡ µû¶ó¼´Â Áö³ªÄ£ ÃÊÁ¶°¨, Àλý¿¡ÀÇ Áö³ªÄ£ Ç㹫°¨ µîÀ» Áõ»óÀ¸·Î ÇÏ¿© ÁÖÀ§¿¡¼ÀÇ ¾Æ¹«¸® ¸¹Àº Ãæ°íµµ ±Í¿¡ µé¾î¿ÀÁö ¾Ê´Â´Ù. ´ë°³ È¥ÀÚ ³õ¾ÆµÎ°Ô µÇ¸é, ²À ÀÚ»ì½Ãµµ¸¦ ÇÏ°Ô µÇ¸ç, ƯÈ÷ °»³â±â ¿ì¿ïÁõ¿¡¼´Â ÀÚ»ìÀÇ ºóµµ°¡ ³ô¾Æ ÀÔ¿øÄ¡·á¸¦ ¿äÇÑ´Ù. |
||
| ILP | inadequate luteal phase; insufficiency of luteal phase; interstitial laser photocoagulation; interst... |
|---|---|
| SPIA | solid-phase immunoabsorption; solid-phase immunoassay |
| MDI | Manic(Mood) Depressive Illness Metered-dose inhaler |
| MAFD | manic affective disorder |
| MD | Doctor of Medicine [Lat. Medicinae Doctor]; magnesium deficiency; main duct; maintenance dose; major... |
| MDI | Manic depressive illness |
|---|---|
| Phase I | phase |
| S phase | synthesis phase |
| APRF | 3/acute phase response factor |
| SPRIA | Solid Phase Radioimmune Assay |
| manic | Affected with mania. (18 Nov 1997) |
|---|---|
| manic-depression | Alternating moods of abnormal highs (mania) and lows (depression). Called bipolar disease because of the swings between these opposing poles in mood. (12 Dec 1998) |
| manic-depressive | 1. Pertaining to a manic-depressive psychosis (bipolar disorder). 2. One suffering from such a disorder. (05 Mar 2000) |
| manic-depressive disease | See manic-depression. (12 Dec 1998) |
| manic-depressive disorder | An obsolete term for one of the mood disorders; i.e., bipolar disorder, depression; affective psychosis, affective disorder, bipolar disorder, and endogenous depression. (05 Mar 2000) |
| manic-depressive illness | Now referred to as bipolar illness, characterised by the occurrence of mania (euphoria) alternating with bouts of depression. (27 Sep 1997) |
| manic-depressive psychosis | Perviously referred to as manic depressive illness, characterised by the occurrence of mania (euphoria) alternating with bouts of depression. (27 Sep 1997) |
| manic episode | Manifestation of a major mood disorder in which there is a distinct period during which the predominant mood of the individual is either elevated, expansive, or irritable, and there are associated symptoms of the excited or manic phase of the bipolar disorder. See: affective disorders, endogenous depression. (05 Mar 2000) |
| manic excitement | An excited mental state seen in a bipolar (manic-depressive) disorder characterised by hyperactivity, talkativeness, flight of ideas, pressured speech, grandiosity, and, occasionally, grandiose delusions. See: mania, manic-depressive. Synonym: acute mania. (05 Mar 2000) |
| manic psychosis | Psychosis with predominant affective features. Synonym: manic psychosis. (05 Mar 2000) |
| disease, manic-depressive | See Manic-depression. (12 Dec 1998) |
| accelerated phase of leukaemia | Refers to chronic myelogenous leukaemia that is progressing. The number of immature, abnormal white blood cells in the bone marrow and blood is higher than in the chronic phase, but not as high as in the blast phase. (12 Dec 1998) |
| acceleration phase | <cell biology, cell culture> A period of increasing growth before the log phase in a culture of microbes. After the culture is started on a medium, at first there is no growth (the lag phase) and then the microbes start to gradually grow (acceleration phase) until they reach a constant maximum rate of growth (log phase). (15 Jan 1998) |
| acute-phase protein | <haematology> These plasma proteins (in addition to fibrinogen) increase 25% or more in response to inflammation and injury are under direct control of interleukin-6 (IL-6) (hepatocyte-stimulating factor). Other proteins which increase are ceruloplasmin, C3 and C4 which increase 50% or more; alpha-1 acid glycoprotein, alpha-1 antitrypsin, haptoglobin and fibrinogen (the major determinant of viscosity 1 ) which increase two- to fourfold; C-reactive protein (CRP) and serum amyloid A which increase several hundred-fold. Despite long-held clinical opinion to the contrary, available data indicate that neither ESR nor measurement of specific acute-phase reactants are useful in excluding underlying infection or inflammation regardless of the pretest probability. These proteins are secreted into the blood in increased or decreased quantities by hepatocytes in response to trauma, inflammation, or disease. They can serve as inhibitors or mediators of the inflammatory processes. Certain acute-phase proteins have been used to diagnose and follow the course of diseases or as tumour markers. See also: amyloid, c-reactive protein, erythrocyte sedimentation rate, viscosity. (25 Jun 1999) |
| acute-phase reaction | <immunology, rheumatology> Refers to the changes in synthesis of certain proteins within the serum during an inflammatory response, which provides rapid protection for the host against microorganisms via non-specific defense mechanisms. It consists of fever, an increase in inflammatory humoral factors, and an increased synthesis by hepatocytes of a number of proteins or glycoproteins usually found in the plasma; the reaction is mediated by endogenous pyrogens, the hypothalamus, adrenal hormones, and other factors. (12 Jul 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|